Breathe freely at night, with no mask and no machine
The Back2Sleep nasopharyngeal tube is a soft device that keeps the airway open during sleep to reduce snoring and apneas in mild to moderate sleep apnea. A discreet approach, documented by clinical research.
See what the studies say →No mask
No machine
or electricity
Discreet & portable
Immediate
use
How it works
A large share of snoring and apneas comes from collapse of the soft palate (the retropalatal area) during sleep. The nasopharyngeal tube acts right at this level.
Gentle insertion
A soft silicone tube is inserted through the nostril until it reaches past the area that becomes blocked behind the soft palate.
Airway support
The tube “stents” the airway and stops the soft palate from falling backward.
Air and quiet restored
Air flows freely: less vibration, so less snoring, and fewer apneas in suitable patients.
What the scientific studies say
Several hospital and university teams have evaluated Nastent, the original name of Back2Sleep. Here are the most notable results, in selected patients, with the conditions of each measurement.
AHI measured under sedation
During a sedated endoscopy at Hôpital Foch, the AHI of 11 patients is 6.0 per hour with the tube, versus 20.5 at their diagnostic test. The authors consider a study during natural sleep necessary.
Snoring gone
During the same endoscopy, snoring disappeared in 10 of 11 patients. Other studies on Nastent (Hirata, Furuie, Ohtsuka) also measure a reduction in snoring.
Lower severity and less snoring
Prospective study: the tube significantly reduces the AHI, desaturations and snoring volume.
Better oxygenation at night
After one month with the tube, minimum oxygen saturation rises and the respiratory event index falls from 22.4 to 15.7 per hour.
Responders with soft palate collapse
In 101 patients, 26% respond to treatment, and 57% when the obstruction is an anteroposterior collapse of the soft palate. The tube has no effect on the tongue base.
Discomfort that fades within a few days
In 14 volunteers, the discomfort index halves between day 4 and day 9 of use.
Who it works best for
As the studies show, the nasopharyngeal tube is not a universal solution. It works mainly when the obstruction is at the level of the soft palate. A medical assessment helps identify the right candidates.
✓ Favorable indications
- ✓ Bothersome simple snoring
- ✓ Mild to moderate sleep apnea
- ✓ Obstruction located at the soft palate
- ✓ Patients who do not tolerate or who refuse CPAP
- ✓ Need for a portable solution
× Less suitable
- × Severe sleep apnea
- × Tongue-base or multilevel obstruction
- × Concentric collapse, large tonsils
- × Complete bilateral nasal obstruction
The publications at a glance
The studies published on Nastent, then a few papers on other nasopharyngeal stents.
| Study | Population | Main result | Access |
|---|---|---|---|
| Tendron, Chabolle, Blumen (Hôpital Foch, Paris) | 11 patients (snoring + mild/moderate sleep apnea) | AHI 20.5 → 6.0 under sedation, snoring gone in 10/11 | Poster (PDF) |
| Okuno et al., 2019 | 30 patients (sleep apnea) | REI 22.4 → 15.7, min. SpO₂ 81.9 → 86.6% | DOI |
| Ohtsuka et al., 2021 | 71 patients (mild/moderate) | ↓ AHI, snoring, desaturations. Effect maintained at 1 month | DOI |
| Hirata & Satoh, 2015 | 6 patients (pilot) | Good tolerance, snoring improved in all | DOI |
| Dellweg, Kampmann, Tschopp, 2022 | 122 patients (101 analyzed) | Responders: 26%, 57% in anteroposterior soft palate collapse. Hard to tolerate | DOI, open access |
| Furuie et al., Tokyo Medical & Dental Univ. | 16 volunteers without sleep apnea (9 snorers) | Discomfort down within a few days, snoring index 0.260 → 0.040 | Poster (PDF) |
| Traxdorf et al., 2016 (AlaxoStent, another device) | 8 patients (vs CPAP) | AHI 31.1 → 19.0 (CPAP: 8.2) | DOI |
| Yenigun et al., 2020 (another device) | 5 patients (feasibility) | Stent placed under endoscopy with sedation: feasibility of soft palate support | DOI |
| Kumar et al., 2015 (meta-analysis, nasopharyngeal airways) | up to 193 patients | AHI 44.1 → 22.7, min oxygenation 66.5 → 75.5% | DOI |
| Victores et al., 2017 (standard nasopharyngeal tube) | 41 patients | Aid to surgical planning (DISE) | DOI |
ⓘ Sources: articles in scientific journals (DOI links) and two congress posters. AHI = apnea-hypopnea index. Some publications are open access, others require a subscription to the publisher.
Important information.
Back2Sleep is a medical device intended for the management of snoring and mild to moderate obstructive sleep apnea. The results shown come from clinical studies in selected patients, often with small sample sizes. They are not indicative of individual results.
A medical device is a regulated health product and, as such, carries the CE marking. Read the instructions for use carefully and ask a healthcare professional for advice.
Sleep apnea is a condition that requires medical diagnosis and follow-up. This device does not replace medical advice or, where relevant, continuous positive airway pressure (CPAP) treatment.
Back2Sleep is the manufacturer of the Class I medical device of the same name. Its registration can be viewed in the European database EUDAMED.